| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944eafb55c46b2d94670fef9aa4937a8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-64 |
| filingDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4bd83ffcd9821987bcd4ecec16a952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2b118e5cb62f1365913258b3671d75a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537db8ad5b21bc807287ea6109600c97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3841aa6f1f6451397689efc914b20793 |
| publicationDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080094312-A |
| titleOfInvention |
Oral Dosage Forms of Protease-Resistant Polypeptides |
| abstract |
An oral dosage form of a therapeutic polypeptide that is protease resistant is provided. Dosage dosages administered per day or week are greater than subcutaneous dosages. Oral dosage forms also include tablets and capsules such as enteric coated formulations. Also provided are methods of treating or preventing a disease or condition that can be treated or prevented by administering an oral dosage form of a protease resistant polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3587443-A4 |
| priorityDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |